Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-20

FDA Approved: DUTASTERIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves Amneal Pharmaceuticals LLC's original abbreviated new drug application for dutasteride (generic) for use in benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DUTASTERIDE (Dutasteride)

Snippet

ORIG AP for DUTASTERIDE (DUTASTERIDE)